Combining the induction of MICA (pro-inflammatory effect) in cancer cells with the specific inhibition of EHHADH and FAO (anti-inflammatory effect) in macrophages may offer a beneficial therapeutic approach for HCC. The gene discussed is MICA; the disease is hepatocellular carcinoma.